APA (7th ed.) Citation

D, B., P, S., JA, S., MA, B., K, F., & M, N. (2024). Enhanced neuronal survival and BDNF elevation via long-term co-activation of galanin 2 (GALR2) and neuropeptide Y1 receptors (NPY1R): Potential therapeutic targets for major depressive disorder. Expert opinion on therapeutic targets, 28(4), 295. https://doi.org/10.1080/14728222.2024.2342517

Chicago Style (17th ed.) Citation

D, Borroto-Escuela, Serrano-Castro P, Sánchez-Pérez JA, Barbancho-Fernández MA, Fuxe K, and Narváez M. "Enhanced Neuronal Survival and BDNF Elevation via Long-term Co-activation of Galanin 2 (GALR2) and Neuropeptide Y1 Receptors (NPY1R): Potential Therapeutic Targets for Major Depressive Disorder." Expert Opinion on Therapeutic Targets 28, no. 4 (2024): 295. https://doi.org/10.1080/14728222.2024.2342517.

MLA (9th ed.) Citation

D, Borroto-Escuela, et al. "Enhanced Neuronal Survival and BDNF Elevation via Long-term Co-activation of Galanin 2 (GALR2) and Neuropeptide Y1 Receptors (NPY1R): Potential Therapeutic Targets for Major Depressive Disorder." Expert Opinion on Therapeutic Targets, vol. 28, no. 4, 2024, p. 295, https://doi.org/10.1080/14728222.2024.2342517.